Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (271-280 of 320) with videos related to

Pageof 32
Sort By:
Circulation Research|January 16, 2015
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol exportXian-Ming Du, Mi-Jurng Kim, Liming Hou, et al.
Atherosclerosis|July 5, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Alberico L Catapano, Zeljko Reiner, et al.
European Heart Journal|June 30, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Zeljko Reiner, Alberico L Catapano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosisMarcia L E MacDonald, Miranda van Eck, Reeni B Hildebrand, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 10, 2012
Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formationMaryline Olivier, Michael W Tanck, Ruud Out, et al.
Atherosclerosis|September 2, 2011
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Alberico L Catapano, Zeljko Reiner, Guy De Backer, et al.
Journal of Clinical Lipidology|October 2, 2013
High-density lipoproteins: a consensus statement from the National Lipid AssociationPeter P Toth, Philip J Barter, Robert S Rosenson, et al.
Journal of the American College of Cardiology|May 28, 2013
High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysisGünther Silbernagel, M John Chapman, Bernd Genser, et al.
Atherosclerosis|June 12, 2012
Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemiaMarianne Abifadel, Maryse Guerin, Suzanne Benjannet, et al.
Revista Espanola De Cardiologia|November 26, 2011
[ESC/EAS Guidelines for the management of dyslipidaemias]Željko Reiner, Alberico L Catapano, Guy De Backer, et al.
Pageof 32

Showing results (271-280 of 320) with videos related to

Sort By:
Pageof 32
Circulation Research|January 16, 2015
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol exportXian-Ming Du, Mi-Jurng Kim, Liming Hou, et al.
Atherosclerosis|July 5, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Alberico L Catapano, Zeljko Reiner, et al.
European Heart Journal|June 30, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Zeljko Reiner, Alberico L Catapano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosisMarcia L E MacDonald, Miranda van Eck, Reeni B Hildebrand, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 10, 2012
Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formationMaryline Olivier, Michael W Tanck, Ruud Out, et al.
Atherosclerosis|September 2, 2011
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Alberico L Catapano, Zeljko Reiner, Guy De Backer, et al.
Journal of Clinical Lipidology|October 2, 2013
High-density lipoproteins: a consensus statement from the National Lipid AssociationPeter P Toth, Philip J Barter, Robert S Rosenson, et al.
Journal of the American College of Cardiology|May 28, 2013
High intestinal cholesterol absorption is associated with cardiovascular disease and risk alleles in ABCG8 and ABO: evidence from the LURIC and YFS cohorts and from a meta-analysisGünther Silbernagel, M John Chapman, Bernd Genser, et al.
Atherosclerosis|June 12, 2012
Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemiaMarianne Abifadel, Maryse Guerin, Suzanne Benjannet, et al.
Revista Espanola De Cardiologia|November 26, 2011
[ESC/EAS Guidelines for the management of dyslipidaemias]Željko Reiner, Alberico L Catapano, Guy De Backer, et al.
Pageof 32